Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 60
Titolo Data di pubblicazione Autore(i) File
Activation of the p53 pathway induces α-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages 2012 Secchiero, Paola; Rimondi, Erika; DI IASIO, Maria Grazia; Voltan, Rebecca; Gonelli, Arianna; Zaul...i, Giorgio file con accesso da definire
Pegylated TRAIL retains anti-leukemic cytotoxicity and exhibits improved signal transduction activity with respect to TRAIL 2012 Gonelli, Arianna; Radillo, O; Drioli, S; Rimondi, Erika; Secchiero, Paola; Maria Bonora, G. file con accesso da definire
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells 2012 Rimondi, Erika; DI IASIO, Maria Grazia; Gonelli, Arianna; Celeghini, C; Secchiero, Paola; Zauli, ...Giorgio file con accesso da definire
Levels of TNF-Related Apoptosis-Inducing Ligand (TRAIL) Show a Long-term Stability in the Breast Milk of Mothers of Preterm Infants 2013 Zauli, Giorgio; Monasta, L; Rimondi, Erika; Vecchi Brumatti, L; Davanzo, R; Demarini, S; Secchier...o, Paola file con accesso da definire
GM-CSF Exhibits Anti-Inflammatory Activity on Endothelial Cells Derived from Chronic Venous Disease Patients 2013 Tisato, Veronica; Secchiero, Paola; Rimondi, Erika; Gianesini, Sergio; Menegatti, Erica; Casciano..., Fabio; Zamboni, Paolo; Zauli, Giorgio
Human Colostrum and Breast Milk Contain High Levels of TNF-Related Apoptosis-Inducing Ligand (TRAIL). 2013 Davanzo, R; Zauli, Giorgio; Monasta, L; Vecchi Brumatti, L; Abate, Mv; Ventura, G; Rimondi, Erika...; Secchiero, Paola; Demarini, S. file con accesso da definire
Sorafenib inhibits in vitro osteoclastogenesis by down-modulating Mcl-1. 2013 Rimondi, Erika; Secchiero, Paola; Melloni, Elisabetta; Grill, V; Zauli, Giorgio file con accesso da definire
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 2014 Agnoletto, Chiara; Melloni, Elisabetta; Casciano, Fabio; Rigolin, Gian Matteo; Rimondi, Erika; Ce...leghini, C; Brunelli, Laura; Cuneo, Antonio; Secchiero, Paola; Zauli, Giorgio
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 2015 Agnoletto, Chiara; Brunelli, Laura; Melloni, Elisabetta; Pastorelli, R; Casciano, Fabio; Rimondi,... Erika; Rigolin, Gian Matteo; Cuneo, Antonio; Secchiero, Paola; Zauli, Giorgio
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy 2015 Tisato, Veronica; Perri, Paolo; Rimondi, Erika; Melloni, Elisabetta; Lamberti, Giuseppe; Milani, ...Daniela; Secchiero, Paola; Zauli, Giorgio
Serum Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Levels in Older Subjects with Dementia and Mild Cognitive Impairment 2016 Tisato, Veronica; Rimondi, Erika; Brombo, Gloria; Volpato, Stefano; Zurlo, Amedeo; Zauli, Giorgio...; Secchiero, Paola; Zuliani, Giovanni
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 2016 Voltan, Rebecca; Rimondi, Erika; Melloni, Elisabetta; Gilli, Paola; Bertolasi, Valerio; Casciano,... Fabio; Rigolin, Gian Matteo; Zauli, Giorgio; Secchiero, Paola
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 2016 Voltan, Rebecca; Rimondi, Erika; Melloni, Elisabetta; Rigolin, Gian Matteo; Casciano, Fabio; Arci...diacono, Maria Vittoria; Celeghini, Claudio; Cuneo, Antonio; Zauli, Giorgio; Secchiero, Paola
Expeditious Synthesis and Biological Characterization of Enantio-Enriched (-)-Nutlin-3 2017 Fantinati, Anna; Bianco, Sara; Cristofori, Virginia; Cavazzini, Alberto; Catani, Martina; Zanirat...o, Vinicio; Pacifico, Salvatore; Rimondi, Erika; Milani, Daniela; Voltan, Rebecca; Secchiero, Paola; Trapella, Claudio
The gamma-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells 2017 Secchiero, Paola; Voltan, Rebecca; Rimondi, Erika; Melloni, Elisabetta; Athanasakis, Emmanouil; T...isato, Veronica; Gallo, Stefania; Rigolin, Gian Matteo; Zauli, Giorgio
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 2018 Arcidiacono, Mv; Rimondi, E; Maietti, E; Melloni, E; Tisato, V; Gallo, S; Valdivielso, Jm; Fernán...dez, E; Betriu, À; Voltan, R; Zauli, G; Volpato, S; Secchiero, P.
Lower maternal serum tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in early preeclampsia. A retrospective study 2018 Morano, Danila; Rolfo, Alessandro; Tisato, Veronica; Farina, Antonio; Rimondi, Erika; Scutiero, G...ennaro; Greco, Pantaleo; Bonaccorsi, Gloria; Todros, Tullia
Effects of intermittent pneumatic compression treatment on clinical outcomes and biochemical markers in patients at low mobility with lower limb edema 2018 Tessari, Mirko; Tisato, Veronica; Rimondi, Erika; Zamboni, Paolo; Malagoni, Anna Maria
A novel endovenous scaffold for the treatment of chronic venous obstruction in a porcine model: Histological and ultrastructural assessment 2019 Zamboni, Paolo; Giaquinta, Alessia; Rimondi, Erika; Pedriali, Massimo; Scanziani, Eugenio; Riccab...oni, Pietro; Veroux, Massimiliano; Secchiero, Paola; Veroux, Pierfrancesco
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 2019 Bernardi, S.; Voltan, R.; Rimondi, E.; Melloni, E.; Milani, D.; Cervellati, C.; Gemmati, D.; Cele...ghini, C.; Secchiero, P.; Zauli, G.; Tisato, V.
Mostrati risultati da 21 a 40 di 60
Legenda icone

  •  file ad accesso aperto
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile